InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: zumantu post# 75469

Wednesday, 03/23/2016 6:33:10 PM

Wednesday, March 23, 2016 6:33:10 PM

Post# of 426270
Zu - interesting article. Did you notice this quote?

They cited trials such as ACCORD, AIM-HIGH and HPS-2 that not only suggested there was no benefit to additional lipid-altering drugs, but also that there could be risks to combining drugs as well. Current guidelines for cholesterol management do not recommend “adding triglyceride-lowering medication to statin therapy in patients with elevated triglycerides,” they wrote.

How strange.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News